首页> 外文期刊>Molecular & cellular proteomics: MCP >Glycation isotopic labeling with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma.
【24h】

Glycation isotopic labeling with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma.

机译:用13C还原糖进行的糖化同位素标记,用于定量分析人血浆中的糖化蛋白。

获取原文
获取原文并翻译 | 示例
           

摘要

Non-enzymatic glycation of proteins is a post-translational modification produced by a reaction between reducing sugars and amino groups located in lysine and arginine residues or in the N-terminal position. This modification plays a relevant role in medicine and food industry. In the clinical field, this undesired role is directly linked to blood glucose concentration and therefore to pathological conditions derived from hyperglycemia (>11 mm glucose) such as diabetes mellitus or renal failure. An approach for qualitative and quantitative analysis of glycated proteins is here proposed to achieve the three information levels for their complete characterization. These are: 1) identification of glycated proteins, 2) elucidation of sugar attachment sites, and 3) quantitative analysis to compare glycemic states. Qualitative analysis was carried out by tandem mass spectrometry after endoproteinase Glu-C digestion and boronate affinity chromatography for isolation of glycated peptides. For this purpose, two MS operational modes were used: higher energy collisional dissociation-MS2 and CID-MS3 by neutral loss scan monitoring of two selective neutral losses (162.05 and 84.04 Da for the glucose cleavage and an intermediate rearrangement of the glucose moiety). On the other hand, quantitative analysis was based on labeling of proteins with [(13)C(6)]glucose incubation to evaluate the native glycated proteins labeled with [(12)C(6)]glucose. As glycation is chemoselective, it is exclusively occurring in potential targets for in vivo modifications. This approach, named glycation isotopic labeling, enabled differentiation of glycated peptides labeled with both isotopic forms resulting from enzymatic digestion by mass spectrometry (6-Da mass shift/glycation site). The strategy was then applied to a reference plasma sample, revealing the detection of 50 glycated proteins and 161 sugar attachment positions with identification of preferential glycation sites for each protein. A predictive approach was also tested to detect potential glycation sites under high glucose concentration.
机译:蛋白质的非酶糖基化是由还原糖和位于赖氨酸和精氨酸残基或N端位置的氨基之间的反应产生的翻译后修饰。这种修饰在医药和食品工业中起着重要的作用。在临床领域,这种不希望有的作用与血糖浓度直接相关,因此与源自高血糖症(> 11 mm葡萄糖)的病理状况(例如糖尿病或肾衰竭)直接相关。本文提出了一种定性和定量分析糖基化蛋白质的方法,以实现三个信息水平的完整表征。它们是:1)糖基化蛋白的鉴定,2)糖基附着位点的阐明,3)定量分析以比较血糖状态。在内蛋白酶Glu-C消化后,通过硼酸亲和色谱法分离糖基化肽,通过串联质谱进行定性分析。为此,使用了两种MS操作模式:通过中性损失扫描监控两个选择性中性损失(葡萄糖裂解的162.05和84.04 Da和葡萄糖部分的中间重排)来进行高能碰撞解离-MS2和CID-MS3。另一方面,定量分析是基于用[(13)C(6)]葡萄糖孵育标记蛋白质来评估用[(12)C(6)]葡萄糖标记的天然糖基化蛋白质。因为糖基化是化学选择性的,所以它仅在体内修饰的潜在靶标中发生。这种方法称为糖基化同位素标记,可以区分用两种同位素形式标记的糖基化肽,这两种同位素形式是通过质谱(6-Da质量转移/糖基化位点)进行酶消化而得到的。然后将该策略应用于参考血浆样品,揭示了50种糖基化蛋白质和161个糖附着位点的检测,并鉴定了每种蛋白质的优先糖基化位点。还测试了一种预测方法来检测高葡萄糖浓度下的潜在糖基化位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号